Dr. Dirk Groenewegen founded and served CEO and Board Member at Glycostem. After an international career as senior R&D-manager in pharmaceutical and chemical multinationals Dirk became a license mediation and new-business consultant, now with 20+ years’ experience. Dirk is an active participant in many international networks, like the Licensing International Society, the Parental Drug Association and various organizations involved in Hematology & Oncology.   He also serves as coach and business expert for EIC Programs and is an investor in start-ups in regenerative medicine.